Indication

IgE-mediated food allergy

IgE-mediated food allergy is an adverse, reproducible type I hypersensitivity reaction driven by allergen-specific immunoglobulin E antibodies directed against dietary proteins. Read more about IgE-mediated food allergy

3 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common IgE-mediated food allergy therapies.

Showing 1–3 of 3 drugs

XOLAIR (omalizumab)

MONOCLONAL ANTIBODIES TO IMMUNOGLOBULIN E (IGE)·CHRONIC IDIOPATHIC URTICARIA·+4
GENENTECH

XOLAIR (omalizumab)

MONOCLONAL ANTIBODIES TO IMMUNOGLOBULIN E (IGE)·CHRONIC IDIOPATHIC URTICARIA·+4
GENENTECH
Filter & compare in the drug finder →Opens the drug finder with IgE-mediated food allergy preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About IgE-mediated food allergy.

IgE-mediated food allergy is an adverse, reproducible type I hypersensitivity reaction driven by allergen-specific immunoglobulin E antibodies directed against dietary proteins.

It affects pediatric and adult populations, commonly manifesting within minutes to a few hours following allergen ingestion or contact.

Pathophysiologically, dietary antigens cross-link specific IgE bound to high-affinity Fc receptors on mast cells and basophils, triggering immediate degranulation and the release of histamine, leukotrienes, and other inflammatory mediators.

Clinical manifestations range from mild cutaneous, gastrointestinal, or mucosal symptoms (such as urticaria, angioedema, pruritus, and emesis) to severe, multi-organ impairment, bronchospasm, cardiovascular collapse, and life-threatening anaphylaxis.

Personalize your experience

Follow IgE-mediated food allergy and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it